-
Innovation Ranking
NewInnovation Ranking – GS Holdings Corp
GS Holdings Corp (GS Holdings) carries out the business of energy, engineering and construction, sports and retail services. The company through its subsidiaries offers oil and gas exploration, and electric and gas utilities. It also carries out the operation of supermarkets, discount stores, convenience stores, commerce stores and department stores, provides home shopping services; retailing electricity, as well as international trade. It also offers hotel, and media and marketing services. The company also operates a football club known as FC...
-
Innovation Ranking
NewInnovation Ranking – GS Yuasa Corp
GS Yuasa Corp (GS Yuasa) is a manufacturer of storage batteries, power supply systems, lighting equipment, and other electrical equipment. The company offers a wide range of products that include automotive and motorcycle batteries, industrial batteries, special batteries, power supply systems, lithium-ion batteries, lighting equipment, ultraviolet irradiation systems, battery charger, and nickel-metal hydride batteries among others. GS Yuasa offers its products to various markets such as original equipment manufacturers and replacement markets. The company’s products find applications in industrial, motorcycles,...
-
Innovation Ranking
NewInnovation Ranking – GS Engineering & Construction Corp
GS E&C Corp (GS E&C) is a heavy construction and civil engineering service provider. It specializes in providing engineering, procurement, and construction (EPC) services for various projects such as office buildings, hospitals, education facilities, sports centers, shopping centers, power, leisure facilities, production facilities and others. GS E&C also carries out construction of expressways, railways, bridges, harbors, apartments and residential complex buildings and others. The company has operations in various countries including the UAE, Spain, the UK, Poland, Italy, Algeria, Saudi...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GS-0201 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GS-0201 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GS-0201 in Solid Tumor Drug Details: Small molecule is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GS-0201 in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GS-0201 in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GS-0201 in Triple-Negative Breast Cancer (TNBC) Drug Details: Small...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GS-1614 in Human Immunodeficiency Virus (HIV) Infections (AIDS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GS-1614 in Human Immunodeficiency Virus (HIV) Infections (AIDS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GS-1614 in Human Immunodeficiency Virus (HIV) Infections...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GS-6212 in Human Immunodeficiency Virus (HIV) Infections (AIDS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GS-6212 in Human Immunodeficiency Virus (HIV) Infections (AIDS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GS-6212 in Human Immunodeficiency Virus (HIV) Infections...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GS-0201 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GS-0201 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GS-0201...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GS-4528 in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GS-4528 in Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GS-4528 in Melanoma Drug Details: GS-4528 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GS-9911 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GS-9911 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GS-9911 in Solid Tumor Drug Details: GS-9911 is under development for...